Acadia is a large U.S. based company who provide a broad range of behavioral healthcare services that target mental health and substance abuse problems in children, teenagers, and adults.
Their inpatient facilities provide approximately 9200 beds in 37 states including the United States, United Kingdom, and Puerto Rico. The company’s outpatient addiction services specialize in opioid addiction and medication-assisted treatment for those suffering with heroin and other opioid dependencies. Each Acadia clinic utilizes methadone and suboxone in their overall treatment.
Acadia recently acquired CRC Health Group and in so doing raised their total number of opioid treatment programs to about 90 – currently making them the single largest provider in the United States.
Acadia just added 10 more clinics to Methadone.US and site visitors can find more information about Acadia’s Opioid Treatment Programs by visiting these recently added cities on the Methadone.US website:
- Clarksburg, WV
- Galax, VA
- LaVale, MD
- Bothell, WA
- Indianapolis, IN
- Fayetteville, NC
- Roanoke, VA
- Charleston, WV
- Santa Ana, CA
- Chattanooga, TN
- San Diego, CA
- Riverside, CA
- Portland, OR
- Louisville, KY
- Baltimore, MD
Posted in Addiction Recovery, California Drug Treatment, Drug Rehab Programs, Heroin, Medication Assisted Treatment, Methadone, Methadone Benefits, Methadone Clinics, Methadone Maintenance, Methadone Programs, Methadone Treatment, Recovery, Suboxone, Suboxone Clinics, Suboxone Doctors
Tagged Acadia, behavioral healthcare, medication-assisted treatment, opioid treatment
Drug and alcohol addiction are treatable illnesses. They can be successfully managed and “arrested” such that they do not continue to harm a person’s life or compromise their health. Just as with any progressive illness, a patient should commit to a course of treatment that has been proven to eradicate their illness or reduce its impact. Heart disease, cancer, diabetes, morbid obesity, alzheimer’s – all of these have established medical treatments which can increase a person’s chance of survival and/or quality of life.
Addiction is both a physiological and behavioral illness. With opioid addiction in particular, there is a strong biological/physical basis as well as a highly significant psychological component. When both of these are adequately addressed, a patient has a new opportunity to recover.
For most individuals with a severe opioid addiction, is critically important to receive physical relief from the discomfort of opioid withdrawal symptoms. But this must also happen in conjunction with behavioral health counseling. Counseling addresses the emotional & psychological factors that contributed to the development of addiction in the first place, and counseling teaches the skills necessary to remain drug free over the long-term and to hopefully avoid future relapses.
Many people find that if they neglect one of these two key areas, then they are more vulnerable to relapse and rapid deterioration. When opioid detox is not a viable option for a particular patient, methadone and suboxone are clearly the medications of choice for addressing opioid withdrawal. Counseling provides the other half of the equation. All methadone programs across the country (as well as all suboxone-approved physicians) are required to insure that their patients are receiving some level of addiction counseling.
The essential ingredient is this mix is patient commitment. Having a genuine desire for a drug free life is as important as anything else. Becoming ready for change is a process in itself and varies from person to person. It is true that many people find their way into recovery because of a recent crisis in which things get so bad they hit a new low, or bottom. This does not have to happen though.
Sometimes hitting “bottom” brings with it dire consequences. If you have been contemplating making a change, please remember that it is not too late. There are many advantages to acting today as opposed to waiting another day. Addiction loves procrastination. Recovery begins now with your commitment to doing something about your problem!
Posted in Addiction Recovery, Addiction Treatment, Buprenorphine, Medication Assisted Treatment, Methadone, Methadone Clinics, Methadone Maintenance, Methadone Success, Methadone Treatment, Opiate Treatment, Recovery, Recovery Support, Suboxone, Suboxone Doctors
Tagged recovery process, relapse prevention
Acadia Healthcare is a leading behavioral healthcare services provider headquartered out of Franklin, Tennessee. The company was established in 2005 and has experienced rapid growth as a result of strategic acquisitions and a sharp focus on the delivery of psychiatric and chemical dependency treatment services.
Acadia recently bought out CRC Health Group for a reported $1.2 billion in a well-publicized sale which closed in February 2015. The acquisition significantly expanded Acadia’s opioid addiction treatment capabilities adding approximately 82 methadone/suboxone facilities nationwide. The company is nicely positioned to serve tens of thousands of patients on a daily basis who are struggling with opioid addiction and other associated illnesses. Methadone and buprenorphine products are utilized in association with a variety of counseling approaches.
Just added to Methadone.US are five of Acadia’s opioid treatment clinics located in San Diego, Riverside, Baltimore, Portland, and Southern Indiana.
Acadia’s mission statement:
Acadia Healthcare’s mission is to create behavioral health centers where people receive care that enables them to regain hope in a supportive, caring environment.
The company presently has behavioral healthcare facilities in 37 U.S. states, the United Kingdom, and Puerto Rico. These include residential treatment centers, inpatient psychiatric hospitals, outpatient clinics, and therapeutic school-based programs.
Posted in Addiction Treatment, Buprenorphine, Drug Rehab Programs, Methadone, Methadone Clinics, Methadone Maintenance, Methadone Programs, Methadone Success, Methadone Treatment, Opiate Addiction, Opiate Treatment, Suboxone, Suboxone Clinics, Suboxone Doctors
Tagged Acadia, CRC Health
Paul LePage, the governor of Maine, has announced that he is considering ceasing state-funded support for methadone. As an alternative, Maine is proposing that patients prescribed methadone be switched to a more affordable suboxone option as part of a $727,000 state budget cut. The story is here.
This is an indefensible decision with dire medical implications for opioid addicted patients currently receiving methadone. It equates to government officials making medical decisions that will negatively impact the health and well-being of thousands of people.
Representative Drew Gattine (a member of the Health & Human Services Committee) is quoted as saying the proposal shows a lack of understanding of the societal costs of addiction throughout the state of Maine.
Methadone and suboxone are both effective medications, but offer very unique characteristics and applications depending on the severity & chronicity of a patient’s opioid addiction. Buprenorphine (the actual opioid agonist contained in suboxone) has a much lower ceiling effect than does methadone meaning its effectiveness would be insufficient for a potentially large percentage of stable methadone patients on 60mg or more of methadone daily. Many patients on a moderate to high maintenance dose of methadone would not have their opioid withdrawal symptoms managed by even the maximum dosage allowed for suboxone – which is generally around 32 mg per day.
For a politician to, in essence, prescribe inappropriate medical treatment for a diagnosable medical condition is a huge state liability. The repercussions are alarming. Hopefully, the local medical establishment and other state officials will step in before irreversible damage is done. Methadone works. This cannot be denied.
Methadone has a long, proven track record of medical efficacy and cost effectiveness. Maine, in particular, has suffered in recent years with a severe opioid addiction epidemic. Reducing access to appropriate medical treatment like methadone will likely result in overdose deaths across Maine and an explosion of condemnation for the governor and his office.
Medication-assisted treatment (MAT) for opioid addiction is not a fad. It is scientifically proven effective and endorsed by multiple state & federal regulatory agencies as well as ASAM.
Posted in Addiction Treatment, Buprenorphine, Drug Treatment, Medication Assisted Treatment, Methadone, Methadone Clinics, Methadone Programs, Methadone Treatment, Opiate Treatment, Recovery, Suboxone, Suboxone Doctors
Tagged LePage, Main
A common question among those seeking help is whether methadone or suboxone is the best choice for opioid replacement therapy. It reminds me of the age old debate … which is better, Ford or Chevy? Methadone has been used in opioid addiction treatment for about 45 years. Suboxone has been available to the public for 12 years. Each of these medications has been shown, through conclusive research, to be highly effective in eliminating opioid withdrawal. Both methadone and suboxone achieve a similar outcome, but with subtle differences. [view our comparison chart]
When opiate withdrawal symptoms are no longer a daily preoccupation and source of anxiety, individuals are free to invest their energy & time in productive, meaningful activities. Avoiding withdrawal sickness is the single greatest driver of continued opioid use, and often pushes an individual to desperate measures to maintain a supply of opiates so that they will not get sick.
People unfamiliar with addiction sometimes believe that an addicted person “just wants to get high”. To the contrary, most people with a chronic opioid addiction are just trying to get by, to get through the day without becoming sick all over again. Opioid withdrawal sickness is an exhausting roller coaster ride that rarely slows down long enough to allow an individual to escape. Their relief from opioid withdrawal sickness is typically short-lived, and they then begin feeling sick all over again. Quite a vicious cycle.
This is why suboxone (buprenorphine) and methadone are so valuable as a medical treatment for opioid addiction. These synthesized opioid replacement medications have a slow onset, long duration of action. This means that they don’t quickly spike to maximum levels in a person’s bloodstream like heroin. They reach maximum benefit several hours after they are taken. They then remain active in a person’s system for more than 24 hours and consequently keep painful withdrawal symptoms away. With no fear of being sick, a person can finally live their life and refocus their time where it needs to be: work, school, family, home, etc.
Methadone is a full opioid agonist whereas buprenorphine (the active ingredient in suboxone) is a partial opioid agonist. Because suboxone is a partial agonist, it is somewhat less susceptible to causing overdose and is considered easier to taper off of as individuals lower their daily dosage. As a result of methadone being a full opioid agonist, it is typically more effective with severe, long-term opioid addictions. Suboxone has a peak benefit at 24-32 mg per day whereby higher dosages than this will not produce additional withdrawal relief. However, methadone has no such “ceiling effect” and much higher dosages can be utilized as needed to eliminate a patient’s opioid withdrawal.